| Followers | 19 |
| Posts | 6566 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Saturday, April 12, 2025 12:45:34 PM
WQLF SAYS; So just the opposite happened. The added 3 million common shares since the 1:6 preferred shares was declined, in my opinion it appears that the company had to find a way to get the majority of the common shareholders to vote in the affirmative for the 1:13 offer and a Reverse split. Why would common shareholders vote for such nonsense and have their shares diluted? Why would the institutional lenders convert their preferred for common shares when they can get more for their preferreds in the short run? Were they an inside plant by those preferred shareholders that would benefit from a 1:13 conversion in order to get a majority of the common shareholders to vote for the conversion? Who would benefit the most for a 1:13 conversion, besides the CEO and some of the directors? What a shame for those that run this company in my opinion of course…Have Mercy WQLF Ahooooooo
Bearish
Recent YCBD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:14:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:05:49 PM
- cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare • PR Newswire (US) • 04/01/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2026 05:15:15 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/04/2026 10:24:35 PM
- cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 • PR Newswire (US) • 02/17/2026 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:16 PM
- cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results • PR Newswire (US) • 02/12/2026 10:31:00 PM
- cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum • PR Newswire (US) • 02/02/2026 02:00:00 PM
- cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways • PR Newswire (US) • 01/29/2026 05:53:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2026 02:14:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/20/2026 09:05:38 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2026 09:18:55 PM
- cbdMD Announces Strategic Acquisition of Bluebird Botanicals • PR Newswire (US) • 01/14/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2026 02:57:14 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 12/23/2025 10:00:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/22/2025 03:36:16 PM
